April 3, 2019
In this 2019 video, Dr. El Demellawy talks about the CAP protocol for examining specimens from pediatric patients with hepatoblastoma
Watch as Dr. Dina El Demellawy talks about how pathologists specializing in pediatric oncology can use CAP to report hepatoblastoma. Dr. Demellawy reviews:
- Tumour size
- Tumour focality
- Macroscopic extent of tumour
- Histologic type
- Treatment effect
- Lymphovascular invasion
- Regional lymph nodes
- Distant metastases
- Additional pathologic findings
- Serum alpha fetoprotein levels
She also highlights changes since the CAP cancer protocol and electronic cancer checklist. In particular, that protocol has been separated into:
CAP education session about pediatric hepatoblastoma
About the presenter, Dr. Dina El Demellawy
Dina El Demellawy, MD, PhD, FRCPC, practices as a Pediatric Pathologist at Children’s Hospital of Eastern Ontario, Ottawa, Canada and is an Associate Professor in the Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of Ottawa. She completed her Anatomical Pathology residency training at the University of Toronto, Ontario and her Pediatric Pathology fellowship training at the University of Pittsburgh Medical Centre, Pennsylvania, U.S.A.
Dr. El Demellawy was appointed a Clinical Investigator at The Children’s Hospital of Eastern Ontario Research Institute. She is the acting chair of Pathology and Laboratory Medicine Committee (PALM). She is a current member of the following committees at the University of Ottawa: Archives Committee on the International Society of Pediatric Pathology, the Residency Pathology Committee, the Faculty Engagement Committee and the Faculty Wellness Program Advisory Committee.
About the CAP education sessions
The Partnership, the Canadian Association of Pathologists (CAP-ACP), and Cancer Care Ontario (CCO) have organized this College of American Pathologists (CAP) education session.
In July 2009, the CAP-ACP endorsed the cancer protocols developed by CAP as the Canada-wide standard for all cancer-pathology reporting. To date, CAP protocols have been implemented in six Canadian provinces with the CAP-ACP’s support.
The protocols help pathologists to report effectively about diagnostic and prognostic findings, which are critical to patient care and the collection of collaborative stage data. The protocols were developed by multidisciplinary teams and are supported by CAP in both paper and electronic formats.